Smith & Nephew SNATS, Inc. (SNN): Price and Financial Metrics

Smith & Nephew SNATS, Inc. (SNN)

Today's Latest Price: $43.67 USD

1.91 (-4.19%)

Updated Jan 27 7:00pm

Add SNN to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 189 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

SNN Stock Summary

  • With a market capitalization of $20,173,876,031, Smith & Nephew Plc has a greater market value than 89.41% of US stocks.
  • With a year-over-year growth in debt of 38.31%, Smith & Nephew Plc's debt growth rate surpasses 78.86% of about US stocks.
  • In terms of volatility of its share price, SNN is more volatile than merely 2.28% of stocks we're observing.
  • Stocks that are quantitatively similar to SNN, based on their financial statements, market capitalization, and price volatility, are STE, COO, CBRE, GIB, and AJG.
  • Visit SNN's SEC page to see the company's official filings. To visit the company's web site, go to

SNN Stock Price Chart Interactive Chart >

Price chart for SNN

SNN Price/Volume Stats

Current price $43.67 52-week high $52.26
Prev. close $45.58 52-week low $26.07
Day low $43.63 Volume 479,800
Day high $44.60 Avg. volume 386,206
50-day MA $41.77 Dividend yield 1.23%
200-day MA $40.31 Market Cap 19.15B

Smith & Nephew SNATS, Inc. (SNN) Company Bio

Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the advanced surgical devices and advanced wound management sectors worldwide. The Company operates in two segments: Advanced Surgical Devices and Advanced Wound Management. The company was founded in 1856 and is based in London, the United Kingdom.

SNN Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$43.67$9.36 -79%

We started the process of determining a valid price forecast for Smith & Nephew Plc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Smith & Nephew Plc ranked in the 19th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 79.33%. The most interesting components of our discounted cash flow analysis for Smith & Nephew Plc ended up being:

  • The company has produced more trailing twelve month cash flow than 78.67% of its sector Healthcare.
  • The business' balance sheet reveals debt to be 5% of the company's capital (with equity being the remaining amount). Approximately only 16.9% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
  • SNN's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 43.13% of tickers in our DCF set.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Smith & Nephew Plc? See GMED, CNMD, LMNX, VAR, and EHC.

SNN Latest News Stream

Event/Time News Detail
Loading, please wait...

SNN Latest Social Stream

Loading social stream, please wait...

View Full SNN Social Stream

Latest SNN News From Around the Web

Below are the latest news stories about Smith & Nephew Plc that investors may wish to consider to help them evaluate SNN as an investment opportunity.

Disposable Clothing Market – Global Industry Analysis, Trends, Production, Revenue, Gross Margin Analysis and Forecast 2021-2027|Key Top Players- Baxter, Medtronic, Ansell, 3M, Terumo Corporation, B. Braun, Smith & Nephew, Medline, Halyard Health, Smith the exclusive leading provider of market research reports published research report on “Global Disposable Clothing Market Research Report 2021”. The Global Disposable Clothing Market Report 2021 is a professional and in-depth study on the current state of the Disposable Clothing

OpenPR | January 22, 2021

Artificial Hip Prosthesis Market Growth Till 2027, In-depth Research Analysis By SMI | Johnson & Johnson, Smith & Nephew, Stryker, Zimmer-Biomet, Altimed, JRI Orthopaedics, Lima Corporate, Corin, Exactech, Elite Surgical, Marle

Artificial hip prosthesis is implant device that is used in hip replacement surgery which includes the removal of the damaged hip bone. The artificial hip prosthesis is mainly composed of plastic and metal components. Hip replacement surgery is mainly done

OpenPR | January 22, 2021

Foot and Ankle Devices Market worth $5.3 billion by 2025 - Leading Key Players are DePuy Synthes Companies (US), Stryker Corporation (US), Zimmer Biomet Holdings, Inc (US), Smith & Nephew plc (UK)

According to the new market research report "Foot and Ankle Devices Market by Product (Implants, Plates, Screw, Wires, Internal Fixators, Braces, Prosthesis (SACH, Single/Multi-Axial)), Application (Rheumatoid Arthritis, Osteoporosis, Hammertoe), Enduser (Hospital, ASCs) - Global Forecasts to 2025", published by MarketsandMarkets™,

OpenPR | January 22, 2021

Knee Replacement Market – Global Industry Analysis, Trends, Production, Revenue, Gross Margin Analysis and Forecast 2021-2027|Key Top Players- Zimmer Biomet, DePuy Synthes, Stryker, Smith & Nephew, Exactech, ConforMis, Aesculap Implant Systems, Arthrex, the exclusive leading provider of market research reports published research report on “Global Knee Replacement Market Size, Status and Forecast 2021-2027”. The Global Knee Replacement Market Report 2021 is a professional and in-depth study on the current state of the

OpenPR | January 21, 2021

Surgical Robots Market: the government of India announced a US$ 9.87 billion outlay for the health sector | Key Players: Intuitive Surgical, Accuray Incorporated, Stryker, MEDTRONIC, Smith & Nephew

A type of minimally invasive surgery that uses robotics to perform surgical procedures is robotic surgery. These robotic systems are operated by surgeons and consist of miniaturized surgical instruments placed on robotic arms, enabling surgeons to precisely conduct the operations.

OpenPR | January 21, 2021

Read More 'SNN' Stories Here

SNN Price Returns

1-mo 1.99%
3-mo 24.52%
6-mo 10.48%
1-year -10.79%
3-year 25.58%
5-year 42.78%
YTD 3.56%
2020 -10.45%
2019 30.78%
2018 8.84%
2017 18.54%
2016 -13.98%

SNN Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full SNN Dividend History

Continue Researching SNN

Here are a few links from around the web to help you further your research on Smith & Nephew Plc's stock as an investment opportunity:

Smith & Nephew Plc (SNN) Stock Price | Nasdaq
Smith & Nephew Plc (SNN) Stock Quote, History and News - Yahoo Finance
Smith & Nephew Plc (SNN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8857 seconds.